719 related articles for article (PubMed ID: 14606082)
1. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
2. [The diagnostic value of eight serum indices for liver fibrosis].
Cai WM; Zhang BB; Weng HL; Hu ZR; Lv J; Zheng M; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):219-22. PubMed ID: 15099471
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effects of qianggan capsule on the liver tissue pathology and PDGF-BB, TGF-beta1, TIMP-1, and MMP-1 factors in patients with chronic hepatitis B].
Wang H; Yang LM; Huang L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1337-40. PubMed ID: 22097200
[TBL] [Abstract][Full Text] [Related]
4. Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-beta1 on activated pancreatic stellate cells.
Kordes C; Brookmann S; Häussinger D; Klonowski-Stumpe H
Pancreas; 2005 Aug; 31(2):156-67. PubMed ID: 16025003
[TBL] [Abstract][Full Text] [Related]
5. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
6. Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
Flisiak R; Al-Kadasi H; Jaroszewicz J; Prokopowicz D; Flisiak I
World J Gastroenterol; 2004 Sep; 10(18):2661-5. PubMed ID: 15309715
[TBL] [Abstract][Full Text] [Related]
7. Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B.
Lou SM; Li YM; Wang KM; Cai WM; Weng HL
World J Gastroenterol; 2004 Feb; 10(3):385-8. PubMed ID: 14760763
[TBL] [Abstract][Full Text] [Related]
8. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
Boeker KH; Haberkorn CI; Michels D; Flemming P; Manns MP; Lichtinghagen R
Clin Chim Acta; 2002 Feb; 316(1-2):71-81. PubMed ID: 11750276
[TBL] [Abstract][Full Text] [Related]
11. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
12. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
[TBL] [Abstract][Full Text] [Related]
13. ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9.
Li X; Meng Y; Yang XS; Mi LF; Cai SX
World J Gastroenterol; 2005 Aug; 11(31):4807-11. PubMed ID: 16097048
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
[TBL] [Abstract][Full Text] [Related]
15. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
Zhou J; Deng Y; Yan L; Zhao H; Wang G;
Int J Infect Dis; 2016 Aug; 49():94-9. PubMed ID: 27292607
[TBL] [Abstract][Full Text] [Related]
16. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
Yin SS; Li XM; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
[TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.
Yilmaz Y; Eren F
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):43-46. PubMed ID: 30134384
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica.
Hou XY; Ellis MK; McManus DP; Wang YY; Li SD; Williams GM; Li YS
Int J Parasitol; 2011 Mar; 41(3-4):325-32. PubMed ID: 21145322
[TBL] [Abstract][Full Text] [Related]
19. [A clinical study on combined serum hepatic fibrosis-related markers and ultrasound parameters to diagnose hepatic fibrosis].
Yu J; Jia CH; Wang Q; Xu PS; Zhang H; Zhao YQ; Shen Q; Hao YR; Cai GF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):56-8. PubMed ID: 17429537
[TBL] [Abstract][Full Text] [Related]
20. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
